Urgent.News

600+ sources. One page. See who else covered it.

Editions

Finance & Markets

Karyopharm has a month left to salvage its cancer expansion plans

A commercial-stage cancer drugmaker with a market cap about one-third the size of its projected 2026 revenues is on the brink of defaulting. Karyopharm Therapeutics said Thursday that it has until ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Finance & Markets

Thai Beverage logs over 7% rise in nine-month profit

BENGALURU — Singapore-listed Thai Beverage (ThaiBev) posted a ‌7.2% rise in nine-month operating earnings on Thursday, helped by...

  • Thai Beverage's nine-month profit rises 7.2%
  • EBITDA reaches 48.29 billion baht (US$1.46 billion)
  • Potential sale of KFC franchise in Thailand discussed

Aradel Holdings to begin petrol production at its modular refinery in 2027

Integrated indigenous energy firm, Aradel Holdings Plc, has revealed plans to commence refining petrol at its modular refinery in 2027.

  • Aradel Holdings to start petrol production at modular refinery in 2027
  • Fuel subsidies removal and downstream oil deregulation make refining profitable
  • Company exploring expansion, crude supply, and aviation fuel production

More from Thursday 13 August →